Epstein-Barr Virus EBV p23 (AA 1-162) Protein

Produktnummer ABIN935324

Dieses Recombinant -Protein wird in Escherichia coli (E. coli) produziert.

Kurzübersicht für Epstein-Barr Virus EBV p23 (AA 1-162) Protein (ABIN935324)

Target: Epstein-Barr Virus EBV p23

Protein-Typ: Recombinant

Spezies: Epstein-Barr Virus (EBV)

Quelle: Escherichia coli (E. coli)

Applikation: ELISA, Western Blotting (WB)

Reinheit: > 95 % pure

Produktdetails

Proteineigenschaft: AA 1-162

Produktmerkmale: Purified recombinant EBV p23 protein
Expression System: E.coli

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Supplied as a liquid with 25 mM glycine, pH-9.6, and 50 % glycerol.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: RT/-20 °C

Antigendetails

Target: Epstein-Barr Virus EBV p23

Substanzklasse: Viral Protein

Hintergrund: The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family (which includes Herpes simplex virusand Cytomegalo virus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions.
Alternative Names: Epstein-Barr Virus p23 protein, Epstein Barr, EBV HHV4 p123 protein